Stock listing

MPLT Stock Price, News, Filings & Events — Maplight Therapeutics, Inc.

Selected listing: MPLT · NASDAQ · USD · US

This page tracks Maplight Therapeutics, Inc.'s MPLT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MPLT:NASDAQ. MPLT:NASDAQ is the stock-level entry point for investors researching Maplight Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maplight Therapeutics, Inc. (ticker: MPLT) is a public company based in the United States with a market capitalization of approximately $1.61 billion. The company focuses on developing innovative therapies aimed at improving patient outcomes. As a publicly traded entity, Maplight Therapeutics is positioned within the healthcare sector, contributing to advancements in medical treatments.

MPLT:NASDAQUSDUSUpdated September 12, 2026
Maplight Therapeutics, Inc. logo
Ticker
MPLT:NASDAQ
Asset type
Stock
Market cap
$687.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Maplight Therapeutics, Inc. MPLT:NASDAQ stock context

This page tracks Maplight Therapeutics, Inc.'s MPLT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MPLT:NASDAQ. MPLT:NASDAQ is the stock-level entry point for investors researching Maplight Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maplight Therapeutics, Inc. (ticker: MPLT) is a public company based in the United States with a market capitalization of approximately $1.61 billion. The company focuses on developing innovative therapies aimed at improving patient outcomes. As a publicly traded entity, Maplight Therapeutics is positioned within the healthcare sector, contributing to advancements in medical treatments.

Latest news from Maplight Therapeutics, Inc.

All Maplight Therapeutics, Inc. news →

Research Maplight Therapeutics, Inc.

Alternate listings